NCT00262041
- Conditions
- Prevention of Meningococcal Disease
- Locations
-
- Rochester, Minnesota, United States
- Pittsburgh, Pennsylvania, United States
- Seattle, Washington, United States
Clinical trial condition
Prevention of Meningococcal Disease
Explore clinical trials studying Prevention of Meningococcal Disease. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
Prevention of Meningococcal Disease trial results
Completed
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children
NCT00262028
- Conditions
- Prevention of Meningococcal Disease
- Locations
-
- Kaiser Permanente Vaccine Study Center Oakland, California, United States
Completed
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants
NCT00262002
- Conditions
- Prevention of Meningococcal Disease
- Locations
-
- Vaccine Evaluation Center Vancouver, British Columbia, Canada
- Clinical Trial Research Center Halifax, Nova Scotia, Canada
- Oxford Vaccine Group Oxford, United Kingdom